Further to our letter dated November 20, 2020, we wish to inform you that Glenmark Pharmaceuticals Limited ("Company") has issued a notice of optional redemption to the holders of U.S. $200 million 4.5% Senior Notes due 2021 ("Notice") listed on the Singapore Exchange Securities Trading Limited, in accordance with the terms of the Indenture dated as of August 1, 2016 (as amended, supplemented, waived or otherwise modified from time to time), between, among others, the Company and Citicorp International Limited, as trustee. Copy of the Notice is attached herewith.